We have detected that you are using some form of ad-blocking or filtering.
Please consider white-listing Labnodes since 1) ad-blockers like uBlock break Labnodes functionality and 2) Labnodes does not serve ads.
Metabolic plasticity in cancer has been linked to the development of drug-tolerant populations. In this issue of , Goldman integrate metabolic plasticity with phenotypic state transitions to examine how this reprogramming can be therapeutically exploited.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
© 2010-2021. All Rights Reserved to Vanderbilt University. Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Released July 13, 2020